blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1054692

EP1054692 - ANTIBODIES AGAINST HUMAN CD40 [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  06.06.2008
Database last updated on 05.10.2024
Most recent event   Tooltip25.07.2008Change - representativepublished on 27.08.2008  [2008/35]
Applicant(s)For all designated states
Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, NJ 08543 / US
[N/P]
Former [2000/48]For all designated states
BRISTOL-MYERS SQUIBB COMPANY
P.O. Box 4000
Princeton, NJ 08543-4000 / US
Inventor(s)01 / ARUFFO, Alejandro, A.
33 Cheston Court
Belle Mead, NJ 08502 / US
02 / HOLLENBAUGH, Diane
344 Wrights Road
Newtown, PA 18940 / US
03 / SIADAK, Anthony, W.
6210 First Avenue, N.W.
Seattle, WA 98107 / US
04 / BERRY, Karen, K.
180 Review Avenue
Lawrenceville, NJ 08648 / US
05 / HARRIS, Linda, J.
1214 16th Avenue, N.E.
Seattle, WA 98112-3313 / US
06 / THORNE, Barbara, A.
3626 223 Avenue, S.E.
Issaquah, WA 98029 / US
07 / BAJORATH, Jurgen
17406 37th Avenue
Lynnwood, WA 98037 / US
08 / WU, Herren
5255 Timber Branch Way
San Diego, CA 92130 / US
09 / HUSE, William, D.
1993 Zapo Street
Del Mar, CA 92014 / US
10 / WATKINS, Jeffry, D.
455 Jolina Way
Encinitas, CA 92024 / US
[2000/48]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2008/35]Vossius & Partner
Siebertstrasse 3
81675 München / DE
Former [2000/48]VOSSIUS & PARTNER
Siebertstrasse 4
81675 München / DE
Application number, filing date99906915.610.02.1999
[2000/48]
WO1999US02949
Priority number, dateUS1998002629119.02.1998         Original published format: US 26291
[2000/48]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO9942075
Date:26.08.1999
Language:EN
[1999/34]
Type: A2 Application without search report 
No.:EP1054692
Date:29.11.2000
Language:EN
The application published by WIPO in one of the EPO official languages on 26.08.1999 takes the place of the publication of the European patent application.
[2000/48]
Search report(s)International search report - published on:US14.10.1999
(Supplementary) European search report - dispatched on:EP12.01.2005
ClassificationIPC:A61K39/395, C07K16/28, C12N15/13
[2000/48]
CPC:
C07K16/2878 (EP,US); C07K16/00 (KR); A61P19/02 (EP);
A61P29/00 (EP); A61P37/02 (EP); A61P37/06 (EP);
A61P43/00 (EP); A61K38/00 (EP,US); C07K2317/24 (EP,US);
C07K2319/00 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2000/48]
Extension statesAL18.09.2000
LT18.09.2000
LV18.09.2000
MK18.09.2000
RO18.09.2000
SI18.09.2000
TitleGerman:ANTIKÖROER GEGEN MENSCHLICHES CD40[2000/48]
English:ANTIBODIES AGAINST HUMAN CD40[2000/48]
French:ANTICORPS CONTRE LE CD40 HUMAIN[2000/48]
Entry into regional phase18.09.2000National basic fee paid 
18.09.2000Search fee paid 
18.09.2000Designation fee(s) paid 
18.09.2000Examination fee paid 
Examination procedure02.09.1999Request for preliminary examination filed
International Preliminary Examining Authority: US
18.09.2000Examination requested  [2000/48]
26.06.2007Despatch of a communication from the examining division (Time limit: M06)
08.01.2008Application deemed to be withdrawn, date of legal effect  [2008/28]
20.02.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2008/28]
Fees paidRenewal fee
15.02.2001Renewal fee patent year 03
13.02.2002Renewal fee patent year 04
12.02.2003Renewal fee patent year 05
12.02.2004Renewal fee patent year 06
14.02.2005Renewal fee patent year 07
14.02.2006Renewal fee patent year 08
14.02.2007Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
29.02.200810   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO9311252  (UNIV CALIFORNIA [US]) [X] 1,4-6 * figures 3d-3f * * 93% identity with seq.ID 3 *;
 [X]WO9632495  (LG CHEMICALS LTD [KR], et al) [X] 1,2,4-7,10-12 * claim 2 * * Light chain seq. 93,5% identity with seq.ID1 * * page 4, lines 16-20 * * page 5, lines 15-19 *;
 [X]WO9731025  (CHIRON CORP [US]) [X] 1-12 * example 8 * * page 1, lines 5-10 *;
 [T]WO0029445  (LG CHEMICAL LTD [KR]) [T] 1,4-6 *claim16a* *seq.ID 3:> 90%identity with seq.ID 8 and 12 of the application* * figure 5 *;
 [X]  - HARTOG DEN M ET AL, "GENERATION OF A HUMANIZED ANTI-CD40 MAB FOR TREATMENT OF AUTOIMMUNE DISEASES", IMMUNOTECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, NL, (199611), vol. 2, no. 4, ISSN 1380-2933, page 299, XP002032468 [X] 1-12 * abstract *
 [T]  - FUNAKOSHI S ET AL, "INHIBITION OF HUMAN B-CELL LYMPHOMA GROWTH BY CD40 STIMULATION", BLOOD, W.B. SAUNDERS, PHILADELPHIA, VA, US, (19940515), vol. 83, no. 10, ISSN 0006-4971, pages 2787 - 2794, XP002919673 [T] 13,14 * the whole document *
 [T]  - LAW CHE-LEUNG ET AL, "Preclinical antitumor activity of a humanized anti-CD40 monoclonal antibody SGN-40.", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (20031116), Database accession no. PREV200400147706, XP002310999 [T] 13,14 * abstract *
 [T]  - BLOOD, 45TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY; SAN DIEGO, CA, USA; DECEMBER 06-09, 2003, (20031116), vol. 102, no. 11, ISSN 0006-4971, page 646a
International search[A]US5677165  (DE BOER MARK [NL], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.